Table 4. Unadjusted and age and sex adjusted proportions (with 95% CI) of deaths attributed to cardiovascular causes by eGFR strata.
| Deaths attributed to | ||||||
|---|---|---|---|---|---|---|
| eGFR strata | Ischaemic heart Disease | Cerebrovascular disease | Heart Failure | Arrythmia | Valvular disease | Other CVD causes |
| >90 ml/min/1.73 m2 | ||||||
| Unadjusted | 47.5 (45.4 to 49.6) | 23.0 (21.2 to 24.7) | 6.3 (5.3 to 7.3) | 2.1 (1.5 to 2.7) | 1.4 (0.9 to 1.9) | 19.7 (18.0 to 21.4) |
| Age/sex adjusted | 41.6 (34.2 to 50.0) | 27.3 (22.2 to 32.4) | 8.9 (6.8 to 11.0) | 2.8 (-13.7 to 19.4) | 1.3 (0.8 to 1.9) | 18.0 (14.5 to 21.6) |
| 60–89 ml/min/1.73 m2 | ||||||
| Unadjusted | 37.6 (36.6 to 38.5) | 23.3 (22.5 to 24.1) | 11.8 (11.2 to 12.4) | 7.5 (7.0 to 8.0) | 2.5 (2.2 to 2.8) | 17.3 (16.6 to 18.1) |
| Age/sex adjusted | 38.1 (22.2 to 54.0) | 23.4 (13.6 to 33.2) | 11.3 (6.5 to 16.0) | 7.0 (-32.0 to 46.0) | 2.5 (1.4 to 3.6) | 17.8 (10.3 to 25.1) |
| 45–59 ml/min/1.73 m2 | ||||||
| Unadjusted | 39.2 (37.9 to 40.5) | 19.5 (18.4 to 20.6) | 13.2 (12.3 to 14.1) | 9.4 (8.6 to 10.2) | 3.4 (2.9 to 3.9) | 15.3 (14.3 to 16.3) |
| Age/sex adjusted | 40.7 (19.9 to 61.5) | 19.3 (9.4 to 29.2) | 12.2 (5.9 to 19.0) | 8.5 (-38.4 to 55.5) | 3.5 (1.7 to 5.4) | 15.8 (7.7 to 23.8) |
| 30–44 ml/min/1.73 m2 | ||||||
| Unadjusted | 39.8 (38.4 to 41.3) | 16.7 (15.6 to 16.7) | 15.1 (14.1 to 16.1) | 8.5 (7.7 to 9.3) | 4.4 (3.8 to 5.0) | 15.5 (14.4 to 16.5) |
| Age/sex adjusted | 41.3 (22.2 to 60.4) | 16.5 (8.8 to 24.1) | 14.0 (7.5 to 20.5) | 7.7 (-35 to 50.5) | 4.6 (2.4 to 6.7) | 16.0 (8.5 to 23.4) |
| 15–29 ml/min 1.73 m2 | ||||||
| Unadjusted | 44.2 (42.3 to 46.2) | 11.9 (10.6 to 13.2) | 18.3 (16.8 to 19.8) | 7.2 (6.2 to 8.2) | 4.0 (3.2 to 4.8) | 14.4 (13.0 to 15.8) |
| Age/sex adjusted | 45.7 (27.6 to 63.8) | 11.8 (7.0 to 16.6) | 17.1 (10.2 to 23.9) | 6.6 (-30.5 to 43.7) | 4.1 (2.3 to 5.9) | 14.8 (8.8 to 20.1) |
| ESRD | ||||||
| Unadjusted | 53.8 (50.1 to 57.5) | 11.5 (9.2 to 13.9) | 15.5 (12.8 to 18.2) | 3.2 (1.9 to 4.5) | 3.1 (1.8 to 4.4) | 12.9 (10.4 to 15.4) |
| Age/sex adjusted | 53.0 (42.3 to 63.6) | 12.0 (8.6 to 15.4) | 15.7 (11.6 to 19.8) | 3.1 (-15.3 to 21.6) | 3.1 (1.7 to 4.6) | 13.1 (9.5 to 16.6) |
| Total (cases) | 10201 | 5026 | 3285 | 1888 | 683 | 4,133 |
CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.